Prosecution Insights
Prosecution Insights
6 pending office actions • 2 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| §112 only | 1 (17%) |
| Double-patenting only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPENCE, JENNIFER SUZANNE | 1 | 66.1% | +50.7% |
| KIM, TAEYOON | 1 | 51.6% | +51.8% |
| GRABER, JAMES J | 1 | 45.9% | +57.0% |
| GONZALES, JOSEPHINE MARIA | 1 | 27.4% | +37.7% |
| STAVROU, CONSTANTINA E | 1 | 44.2% | +36.3% |
| NOBLE, MARCIA STEPHENS | 1 | 67.0% | +40.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18449100 | GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD | GRABER, JAMES J | 27d |
| 17931669 | METHODS FOR THE PRODUCTION OF COMMITTED CARDIAC PROGENITOR CELLS | GONZALES, JOSEPHINE MARIA | 62d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18449100 | GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD | GRABER, JAMES J | 27d |
| 17931669 | METHODS FOR THE PRODUCTION OF COMMITTED CARDIAC PROGENITOR CELLS | GONZALES, JOSEPHINE MARIA | 62d |
| 18824380 | METHOD FOR DIFFERENTIATION OF OCULAR CELLS AND USE THEREOF | SPENCE, JENNIFER SUZANNE | — |
| 18769320 | METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS | KIM, TAEYOON | — |
| 17931440 | COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF | STAVROU, CONSTANTINA E | — |
| 16782772 | METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS | NOBLE, MARCIA STEPHENS | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 1632 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18824380 | METHOD FOR DIFFERENTIATION OF OCULAR CELLS AND USE THEREOF | SPENCE, JENNIFER SUZANNE | — | DP | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18769320 | METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS | KIM, TAEYOON | — | §102§103§112DP | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18449100 | GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD | GRABER, JAMES J | 1631 | §103§112Other | Non-Final OA | 27d | Pending | Aug 14, 2023 |
| 17931669 | METHODS FOR THE PRODUCTION OF COMMITTED CARDIAC PROGENITOR CELLS | GONZALES, JOSEPHINE MARIA | 1631 | §102§103 | Final Rejection | 62d | Pending | Sep 13, 2022 |
| 17931440 | COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF | STAVROU, CONSTANTINA E | 1632 | §103 | Final Rejection | — | Pending | Sep 12, 2022 |
| 16782772 | METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS | NOBLE, MARCIA STEPHENS | 1632 | §112 | Final Rejection | — | Pending | Feb 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial